General Information of Drug (ID: DM80HOV)

Drug Name
SDF-1 Drug Info
Synonyms JVS-100
Indication
Disease Entry ICD 11 Status REF
Heart failure BD10-BD13 Phase 2 [1]
Peripheral arterial disease BD4Z Phase 2 [2]
Cross-matching ID
TTD Drug ID
DM80HOV

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dociparstat sodium DMQLSMB Acute myeloid leukaemia 2A60 Phase 3 [4]
MyoCell SDF-1 DMS9GE1 Heart failure BD10-BD13 Phase 3 [5]
NOX-A12 DMMKN4Q Macular degeneration 9B78.3 Phase 1 [6]
REC-02 DMHT5XV Congestive heart failure BD10 Phase 1 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Stromal cell-derived factor 1 (CXCL12) TT4UGTF SDF1_HUMAN Inhibitor [3]

References

1 ClinicalTrials.gov (NCT01643590) Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 SDF-1 in myocardial repair. Gene Ther. 2012 Jun;19(6):583-7.
4 Clinical pipeline report, company report or official report of Chimerix.
5 Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine. Expert Opin Biol Ther. 2011 Feb;11(2):189-97.
6 SDF-1/CXCR4/CXCR7 is pivotal for vascular smooth muscle cell proliferation and chronic allograft vasculopathy. Transpl Int. 2015 Dec;28(12):1426-35.